Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -177.07% | 29.91% | -10.19% | -10.32% | -0.95% |
| Total Depreciation and Amortization | -44.95% | -3.91% | 0.16% | -2.23% | 44.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,594.43% | -9.74% | 37.24% | 23.94% | 15.50% |
| Change in Net Operating Assets | 35.55% | -171.57% | 181.36% | -134.62% | 280.69% |
| Cash from Operations | -3.04% | 10.66% | 21.36% | -226.24% | 53.43% |
| Capital Expenditure | 52.00% | -25.00% | -17.65% | 91.80% | 70.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.03% | 169.63% | -133.92% | 2,605.71% | 82.95% |
| Cash from Investing | 96.37% | 167.22% | -134.47% | 1,285.57% | 78.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 196.88% | 2,460.00% | -97.09% | -81.55% | 28.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 196.88% | 2,460.00% | -97.09% | -81.55% | 28.02% |
| Foreign Exchange rate Adjustments | 3,850.00% | 77.78% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.35% | 69.03% | -459.16% | 191.10% | 66.61% |